Remdesivir therapy causing bradycardia in COVID-19 patients: Two case reports
The coronavirus disease 2019 (COVID-19) pandemic has been an enormous public health challenge. The pursuit for an effective therapy led to the use of the antiviral drug Remdesivir for hospitalized patients with severe COVID-19 pneumonia. We reported two cases of patients with severe COVID-19 pneumon...
Main Authors: | Alaaeldin Abdelmajid, Wala Osman, Huda Musa, Hisham Elhiday, Waqar Munir, Muna A. Al.Maslamani, Eman Zeyad Elmekaty |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | IDCases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214250921002109 |
Similar Items
-
Prominent bradycardia in a COVID-19 patient receiving Remdesivir: a case report
by: Sidhi Laksono Purwowiyoto, et al.
Published: (2022-07-01) -
Sinus Bradycardia Associated with Remdesivir Treatment in COVID-19: A Case Report and Literature Review
by: Fotios Barkas, et al.
Published: (2021-02-01) -
Remdesivir associated sinus bradycardia in patients with COVID-19: A prospective longitudinal study
by: Maryam Hajimoradi, et al.
Published: (2023-01-01) -
Remdesivir-induced symptomatic bradycardia in the treatment of COVID-19 disease
by: Jomel Patrick Jacinto, DO, et al.
Published: (2021-08-01) -
Incidence and potential risk factors for remdesivir-associated bradycardia in hospitalized patients with COVID-19: A retrospective cohort study
by: Yazed Saleh Alsowaida, et al.
Published: (2023-02-01)